Stay updated on Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.

Latest updates to the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page
- ChecktodayChange DetectedThe study record now indicates that results are posted, including an Adverse Events section, and reflects updated study status and contacts/locations. A new version dated 2026-09-03 was added to the record history.SummaryDifference0.3%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe record history now shows the latest revision as v3.7.0, replacing the previous v3.6.6. This updates the revision label used in the study record history.SummaryDifference0.0%

- Check36 days agoChange DetectedVersion 64 was added on 2026-07-31, introducing a Quality Control status Has Not Concluded and new entries for Adverse Events and Study Status. The record now shows a Returned date of 2026-08-24 and a revision update to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.3%

- Check57 days agoChange DetectedRevision indicator updated from v3.6.4 to v3.6.5 on the page, indicating a newer build of the interface. This is a minor update to the site's metadata rather than a change to study content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page shows an updated revision tag from v3.6.3 to v3.6.4, indicating a small platform update to the Record History view. The change does not appear to alter study information or navigation.SummaryDifference0.0%

- Check78 days agoChange DetectedReturned: 2026-07-10 is now shown and the QC status is Has Not Concluded. New sections have been added to the history view, including More Information, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Documents Section, Contacts/Locations, and an updated Study Status entry (2026-06-15, 63).SummaryDifference0.6%

Stay in the know with updates to Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.